Considerable efforts have been exerted to implement Pharmacogenomics (PGx), the study
of interindividual variations in DNA sequence related to drug response, into routine clinical …

The implementation of genetic data for a better prediction of response to medications and
adverse drug reactions is becoming a reality in some clinical fields. However, to be …

To develop a benchmark measure of US physicians' level of knowledge and extent of use of
pharmacogenomic testing, we conducted an anonymous, cross‐sectional, fax‐based …

Background The use of pharmacogenomic testing in the clinical setting has the potential to
improve the safety and effectiveness of drug therapy, yet studies have revealed that …

Observations over the later half of the last century have suggested that genetic factors may
be the prime determinant of drug response, at least for some drugs. Retrospectively …

With the trend towards promoting personalised medicine (PM), the application of
pharmacogenetics and pharmacogenomics (PGx) is of growing importance. For the …

Aim: The need for pharmacogenomic education is becoming more and more urgent. Our aim
was to evaluate the progress in pharmacogenomics education since then, and to put forward …

The current description of personalized medicine by the National Institutes of Health is “the
science of individualized prevention and therapy.” Although physicians are beginning to see …

Pharmacogenomics (PGx) is rapidly growing branch of molecular genetics with high
potentials to influence therapeutics. This review evaluates knowledge and attitudes of …

Only a few studies have addressed the cost-effectiveness of pharmacogenetics interventions
in healthcare. Lack of health economics data on aspects of pharmacogenetics is perceived …